- Home
- LTC vs CLDX Comparison
LTC vs CLDX Comparison
Compare LTC & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTC | CLDX |
|---|---|---|
| Founded | 1992 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 1992 | 2008 |
Fundamental Metrics
Financial Performance| Metric | LTC | CLDX |
|---|---|---|
| Price | $34.50 | $25.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 10 |
| Target Price | $39.00 | ★ $44.10 |
| AVG Volume (30 Days) | 399.2K | ★ 739.2K |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | ★ 6.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $226,987,000.00 | $2,599,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.49 | $19.70 |
| P/E Ratio | $47.84 | ★ N/A |
| Revenue Growth | ★ 14.23 | N/A |
| 52 Week Low | $31.70 | $14.40 |
| 52 Week High | $37.25 | $30.50 |
Technical Indicators
Market Signals| Indicator | LTC | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 41.01 |
| Support Level | $34.28 | $27.51 |
| Resistance Level | $35.28 | $28.79 |
| Average True Range (ATR) | 0.55 | 1.37 |
| MACD | -0.13 | -0.35 |
| Stochastic Oscillator | 10.87 | 5.96 |
Price Performance
Historical ComparisonAbout LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.